Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (131-140 of 473) with videos related to

Pageof 48
Sort By:
Diagnostic Microbiology and Infectious Disease|May 8, 2020
Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanismsRodrigo E Mendes, Michael D Huband, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitalsMariana Castanheira, Timothy B Doyle, Caitlin J Smith, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2018
Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16)Michael A Pfaller, Helio S Sader, Mariana Castanheira, et al.
Journal of Global Antimicrobial Resistance|November 4, 2018
Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolatesSarah E Costello, Lalitagauri M Deshpande, Andrew P Davis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|July 9, 2020
Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014-2018): therapeutic options for multidrug-resistant bacteriaHelio S Sader, Mariana Castanheira, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec typesMariana Castanheira, Helio S Sader, David J Farrell, et al.
International Journal of Antimicrobial Agents|February 14, 2024
Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022)Helio S Sader, Cecilia G Carvalhaes, John H Kimbrough, et al.
Microbiology Spectrum|October 10, 2024
<i>In vitro</i> activity assessment of cefiderocol against Enterobacterales, <i>Pseudomonas aeruginosa,</i> and <i>Acinetobacter</i> spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitalsJohn H Kimbrough, Joshua M Maher, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)|April 29, 2025
Characterization of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i> Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospitals and Activity of Aztreonam-Avibactam and Comparator Agents (2019-2023)Helio S Sader, Timothy B Doyle, John H Kimbrough, et al.
Pageof 48

Showing results (131-140 of 473) with videos related to

Sort By:
Pageof 48
Diagnostic Microbiology and Infectious Disease|May 8, 2020
Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanismsRodrigo E Mendes, Michael D Huband, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitalsMariana Castanheira, Timothy B Doyle, Caitlin J Smith, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2018
Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16)Michael A Pfaller, Helio S Sader, Mariana Castanheira, et al.
Journal of Global Antimicrobial Resistance|November 4, 2018
Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolatesSarah E Costello, Lalitagauri M Deshpande, Andrew P Davis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|July 9, 2020
Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014-2018): therapeutic options for multidrug-resistant bacteriaHelio S Sader, Mariana Castanheira, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec typesMariana Castanheira, Helio S Sader, David J Farrell, et al.
International Journal of Antimicrobial Agents|February 14, 2024
Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022)Helio S Sader, Cecilia G Carvalhaes, John H Kimbrough, et al.
Microbiology Spectrum|October 10, 2024
<i>In vitro</i> activity assessment of cefiderocol against Enterobacterales, <i>Pseudomonas aeruginosa,</i> and <i>Acinetobacter</i> spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitalsJohn H Kimbrough, Joshua M Maher, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)|April 29, 2025
Characterization of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i> Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospitals and Activity of Aztreonam-Avibactam and Comparator Agents (2019-2023)Helio S Sader, Timothy B Doyle, John H Kimbrough, et al.
Pageof 48